BR9706792A - Derivado de tiazol - Google Patents

Derivado de tiazol

Info

Publication number
BR9706792A
BR9706792A BR9706792-0A BR9706792A BR9706792A BR 9706792 A BR9706792 A BR 9706792A BR 9706792 A BR9706792 A BR 9706792A BR 9706792 A BR9706792 A BR 9706792A
Authority
BR
Brazil
Prior art keywords
threonine
thiazole derivative
protein kinase
lower alkyl
protein
Prior art date
Application number
BR9706792-0A
Other languages
English (en)
Inventor
Toyoki Mori
Michiaki Tominaga
Fujio Tabusa
Kazuyoshi Nagami
Aoru Abe
Kenji Nakaya
Isao Takemura
Tomoichi Shinohara
Oshihisa Tanada
Takahito Yamauchi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of BR9706792A publication Critical patent/BR9706792A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Patente de Invenção: "DERIVADO DE TIAZOL". Um composto detiazol da fórmula: em que T é alquileno inferior; u é 0 ou 1; R^ 1^ eR^ 2^ são os mesmos ou diferentes e são cada um H, ou alquilainferior, etc.; R^ 3^ é R^ 4^ é H ou alcanoilóxi inferior-alquilainferior, que mostra atividade inibitória sobre quinase C de proteína(PKC, fosfatase de proteína de treonina/serina dependentefosfolípidio/Ca^ 2+^) e é útil como um inibidor de quinase C deproteína.
BR9706792-0A 1996-07-31 1997-07-29 Derivado de tiazol BR9706792A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20089896 1996-07-31
PCT/JP1997/002609 WO1998004536A1 (en) 1996-07-31 1997-07-29 Thiazole derivative as protein kinase c inhibitors

Publications (1)

Publication Number Publication Date
BR9706792A true BR9706792A (pt) 2001-11-27

Family

ID=16432095

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9706792-0A BR9706792A (pt) 1996-07-31 1997-07-29 Derivado de tiazol

Country Status (16)

Country Link
US (1) US6140330A (pt)
EP (1) EP0858452B1 (pt)
KR (1) KR19990063910A (pt)
CN (1) CN1070856C (pt)
AR (1) AR008111A1 (pt)
AT (1) ATE214381T1 (pt)
AU (1) AU695817B2 (pt)
BR (1) BR9706792A (pt)
CA (1) CA2233611A1 (pt)
DE (1) DE69711020T2 (pt)
DK (1) DK0858452T3 (pt)
ES (1) ES2179355T3 (pt)
ID (1) ID19474A (pt)
PT (1) PT858452E (pt)
TW (1) TW513418B (pt)
WO (1) WO1998004536A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849769A (en) * 1994-08-24 1998-12-15 Medivir Ab N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection
CN1158269C (zh) 1997-10-27 2004-07-21 阿古龙制药公司 作为cdk抑制剂的取代的4-氨基-噻唑-2-基化合物
NZ503491A (en) 1997-11-10 2002-08-28 Bristol Myers Squibb Co 2-substituted amino-1,3-benzothiazole derivatives useful as protein tyrosine kinase inhibitors
CN1308619A (zh) * 1998-05-12 2001-08-15 美国家用产品公司 (2－酰氨基噻唑－4－基)乙酸衍生物
US6407124B1 (en) 1998-06-18 2002-06-18 Bristol-Myers Squibb Company Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
AU768751B2 (en) * 1998-06-18 2004-01-08 Bristol-Myers Squibb Company Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
GB9823871D0 (en) * 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
US6114365A (en) * 1999-08-12 2000-09-05 Pharmacia & Upjohn S.P.A. Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
TWI284639B (en) * 2000-01-24 2007-08-01 Shionogi & Co A compound having thrombopoietin receptor agonistic effect
WO2001056567A1 (en) * 2000-02-04 2001-08-09 Novo Nordisk A/S 2,4-diaminothiazole derivatives and their use as glycogen synthase kinase-3 (gsk-3) inhibitors
PL357099A1 (en) 2000-02-07 2004-07-12 Abbott Gmbh & Co.Kg 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
DE60212836T2 (de) * 2001-05-16 2007-01-25 Gpc Biotech Ag Pyridylpyrimidin-derivate als wirksame verbindungen gegen prionen-krankheiten
HN2002000156A (es) 2001-07-06 2003-11-27 Inc Agouron Pharmaceuticals Derivados de benzamida tiazol y composiciones farmaceuticas para inhibir la proliferacion de celulas y metodos para su utilización.
EP1724270A3 (en) 2001-07-19 2007-01-03 Pfizer Italia S.r.l. Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
JP2006508174A (ja) * 2002-01-25 2006-03-09 ファルマシア・コーポレーション 炎症関連疾患を予防または治療するためのアルドステロンブロッカー療法
US7101898B2 (en) * 2002-02-01 2006-09-05 Novo Nordisk A/S Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
KR100776961B1 (ko) * 2003-08-12 2007-11-28 시오노기세이야쿠가부시키가이샤 트롬보포이에틴 수용체 아고니스트 작용을 가지는 화합물
WO2006032273A1 (en) * 2004-09-22 2006-03-30 H. Lundbeck A/S 2-acylaminothiazole derivatives
US7674912B2 (en) * 2005-04-25 2010-03-09 H. Lundbeck A/S Pro-drugs of N-thiazol-2-yl-benzamide derivatives
MX2009000475A (es) * 2006-07-19 2009-07-10 Astrazeneca Ab Nuevos compuestos de espiropiperidina triciclicos, su sintesis y sus usos como moduladores de la actividad de los receptores de quimioquinas.
WO2009011653A1 (en) * 2007-07-17 2009-01-22 Astrazeneca Ab A process for the preparation of intermediates and their us in the synthesis of spiropiperidine compounds
WO2009120826A1 (en) * 2008-03-27 2009-10-01 Wyeth 2-aryl- and 2-heteroarylthiazolyl compounds, methods for their preparation and use thereof
SG178853A1 (en) * 2009-08-28 2012-04-27 Array Biopharma Inc Raf inhibitor compounds and methods of use thereof
US8440665B2 (en) * 2010-07-02 2013-05-14 Gilead Sciences, Inc. Apoptosis signal-regulating kinase inhibitors
WO2012104857A1 (en) * 2011-02-04 2012-08-09 Council Of Scientific & Industrial Research Amidobenzothiazoles and process for the preparation thereof
ES2489297B1 (es) * 2013-01-22 2015-06-10 Consejo Superior De Investigaciones Científicas (Csic) Benzotiazoles sustituidos y sus aplicaciones terapeuticas para el tratamiento de enfermedades humanas
GB201401886D0 (en) 2014-02-04 2014-03-19 Lytix Biopharma As Neurodegenerative therapies
CN110317230B (zh) * 2018-03-30 2023-11-07 上海昇悦医药科技有限公司 磷酸盐类衍生物及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063564A1 (en) * 1980-11-04 1982-11-03 ANDERSON, Martin C. Basic color media set for providing tonally matched palettes
CA1322005C (en) * 1987-11-25 1993-09-07 Robert N. Young Benzoheterazoles
IL90337A0 (en) * 1988-05-24 1989-12-15 Pfizer Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
JP2869561B2 (ja) * 1989-05-22 1999-03-10 大塚製薬株式会社 血小板粘着抑制剤
TW205041B (pt) * 1989-08-07 1993-05-01 Fujisawa Pharmaceutical Co
CA2132722A1 (en) * 1992-04-10 1993-10-28 Robert Zamboni Benzothiazole-substituted benzyl alcohols as leukotriene antogonists
CA2132724A1 (en) * 1992-04-10 1993-10-28 Robert Zamboni Thiazole-substituted benzyl alcohols as leukotriene antagonists
DE69420345T2 (de) * 1993-02-19 1999-12-30 Asahi Kasei Kogyo K.K., Osaka Benzothiazolsulfonamid-derivate, verfahren zu deren herstellung und anwendungen

Also Published As

Publication number Publication date
DK0858452T3 (da) 2002-05-21
PT858452E (pt) 2002-07-31
HK1016586A1 (en) 1999-11-05
ES2179355T3 (es) 2003-01-16
DE69711020T2 (de) 2002-11-21
AU3635497A (en) 1998-02-20
CN1070856C (zh) 2001-09-12
EP0858452A1 (en) 1998-08-19
EP0858452B1 (en) 2002-03-13
CA2233611A1 (en) 1998-02-05
ID19474A (id) 1998-07-16
AR008111A1 (es) 1999-12-09
US6140330A (en) 2000-10-31
TW513418B (en) 2002-12-11
WO1998004536A1 (en) 1998-02-05
KR19990063910A (ko) 1999-07-26
DE69711020D1 (de) 2002-04-18
ATE214381T1 (de) 2002-03-15
CN1198160A (zh) 1998-11-04
AU695817B2 (en) 1998-08-20

Similar Documents

Publication Publication Date Title
BG101422A (bg) Бензоксазолни производни като бронхоразширяващи средства
AR008111A1 (es) Compuesto de tiazol, inhibidor de proteina quinasa c que lo comprende y procedimiento para preparar dicho compuesto.
TR199902400T2 (xx) Fungusit etkinlik g�steren terkiplerin birle�imleri.
HRP20000469B1 (hr) Biciklički heteroaromatični spojevi kao inhibitori protein -tirozin kinaze
ATE296303T1 (de) Farnesyltransferase inhibitoren
BR0115452A (pt) Compostos tendo atividade fungicida e processos para fabricação e uso dos mesmos
WO2001019828A3 (en) Kinase inhibitors as therapeutic agents
TR199800773T2 (xx) Trombin inhibit�rleri.
BR0211750A (pt) Agente antiviral
PT1140993E (pt) Derivados de glicopeptidos e composicoes farmaceuticas contendo os mesmos
EP1379251A4 (en) INGREDIENTS OF THE ACT ACTIVITY
DE69924595D1 (de) System für magnetorheologische Feinstbearbeitung von Substraten
DK0840732T3 (da) Substituerede benzolactamforbindelser som substans P-antagonister
WO1999002514A3 (en) Epothilone derivatives
BR9806752A (pt) Ftalazinonas.
WO2003084473A3 (en) Method of treating cancer
BR0112370A (pt) Derivados de glutaramida substituìda com ciclopentila como inibidores de endopeptidase neutra
EP1126849A4 (en) HETEROCYCLIC POTASSIUM CHANNEL INHIBITORS
NO862208D0 (no) Fremgangsmaate fpr fremstilling av heterocykliske forbindelser.
BR0110404A (pt) Derivados de imidazopirimidina e derivados de triazolpirimidina
EA200000098A1 (ru) 4-АМИНОПИРРОЛ(3,2-d)ПИРИМИДИНЫ В КАЧЕСТВЕ АНТАГОНИСТОВ РЕЦЕПТОРА НЕЙРОПЕПТИДА Y
FI902555A0 (fi) Diarylstyrylkinolindisyror.
BR9916328A (pt) Inibidores de transferase de farnesila
PT918776E (pt) Sintese total de acilfulvenos antitumorais
ATE225771T1 (de) Prostaglandin-pharmazeutische-zusammensetzungen

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements